These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34463546)

  • 1. Drug Release and Pharmacokinetic Evaluation of Novel Implantable Mometasone Furoate Matrices in Rabbit Maxillary Sinuses.
    You C; Tseng LF; Pappas A; Concagh D; Kuang Y
    Am J Rhinol Allergy; 2022 Mar; 36(2):198-206. PubMed ID: 34463546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis.
    Ow RA; Shotts S; Kakarlapudi V; McIntyre J; Naclerio RM; You C; Pappas A; Brayton L; Kuang Y; Shao J
    Am J Rhinol Allergy; 2022 Nov; 36(6):733-740. PubMed ID: 35708181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps.
    Kern RC; Stolovitzky JP; Silvers SL; Singh A; Lee JT; Yen DM; Iloreta AMC; Langford FPJ; Karanfilov B; Matheny KE; Stambaugh JW; Gawlicka AK;
    Int Forum Allergy Rhinol; 2018 Apr; 8(4):471-481. PubMed ID: 29350840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porous silicon embedded in a thermoresponsive hydrogel for intranasal delivery of lipophilic drugs to treat rhinosinusitis.
    Bakshi S; Pandey P; Mohammed Y; Wang J; Sailor MJ; Popat A; Parekh HS; Kumeria T
    J Control Release; 2023 Nov; 363():452-463. PubMed ID: 37769816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EVALUATIONS OF SENSORY ATTRIBUTE OF INTRANASAL CORTICOSTEROID SPRAYS IN HEALTHY VOLUNTEERS].
    Watanabe T; Suzuki M
    Arerugi; 2018; 67(2):124-128. PubMed ID: 29553112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays.
    Amini E; Berger SM; Schilling U; Jiao Y; Chen MJ; Bachhav S; Baumstein SM; Tang Y; Al-Humiari M; Leon Astudillo CE; Drescher S; Iley T; Shur J; Price R; Carrasco C; Conti DS; Delvadia R; Oguntimein O; Witzmann K; Absar M; Luke MC; Boc S; Dhapare S; Saluja B; Bielski E; Newman B; Bulitta JB; Hochhaus G
    Mol Pharm; 2023 Nov; 20(11):5690-5700. PubMed ID: 37773975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a combination of mometasone furoate, levofloxacin, and retinyl palmitate with an in situ gel-forming nasal delivery system on nasal mucosa damage repair in an experimental rabbit model.
    Aksoy F; Dogan R; Ozturan O; Altuntas E; Yener FG; Topcu G; Guler B
    Biomed Pharmacother; 2017 Dec; 96():603-611. PubMed ID: 29035825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mometasone furoate sinus implant - a new targeted approach to treating recurrent nasal polyp disease.
    Shen J; Welch K; Kern R
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1163-1170. PubMed ID: 30457411
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of intranasal mometasone in the fixed-dose combination GSP301 versus two monotherapy intranasal mometasone formulations.
    Patel P; Salapatek AM; Talluri RS; Tantry SK
    Allergy Asthma Proc; 2018 May; 39(3):232-239. PubMed ID: 29669668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of intranasal glucocorticosteroids in the treatment of rhinosinusitis: Focus on mometasone furoate].
    Ushkalova EA; Zyryanov SK; Shvarts GY
    Vestn Otorinolaringol; 2016; 81(5):59-66. PubMed ID: 27876741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 clinical study to assess the safety of a novel drug delivery system providing long-term topical steroid therapy for chronic rhinosinusitis.
    Douglas RG; Psaltis AJ; Rimmer J; Kuruvilla T; Cervin A; Kuang Y
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):378-387. PubMed ID: 30645028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of topical agents on paranasal sinus mucosa healing: a rabbit study.
    Jain R; Kim R; Waldvogel-Thurlow S; Hwang P; Cornish J; Douglas R
    Int Forum Allergy Rhinol; 2015 Apr; 5(4):310-7. PubMed ID: 25677963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled steroid delivery via bioabsorbable stent: safety and performance in a rabbit model.
    Li PM; Downie D; Hwang PH
    Am J Rhinol Allergy; 2009; 23(6):591-6. PubMed ID: 19958608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing Biodegradable Nanoparticles Loaded with Mometasone Furoate for Potential Nasal Drug Delivery.
    Far J; Abdel-Haq M; Gruber M; Abu Ammar A
    ACS Omega; 2020 Apr; 5(13):7432-7439. PubMed ID: 32280885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mometasone furoate-impregnated biodegradable nasal dressing on endoscopic appearance in healing process following endoscopic sinus surgery: a randomized, double-blind, placebo-controlled study.
    Zhao KQ; Yu YQ; Yu HM
    Int Forum Allergy Rhinol; 2018 Nov; 8(11):1233-1241. PubMed ID: 30281941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis.
    Yonezaki M; Akiyama K; Karaki M; Goto R; Inamoto R; Samukawa Y; Kobayashi R; Kobayashi E; Hoshikawa H
    Auris Nasus Larynx; 2016 Jun; 43(3):292-7. PubMed ID: 26498699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
    Kosoglou T; Hubbell J; Xuan F; Cutler DL; Meehan AG; Kantesaria B; Wittmer BA
    Int J Chron Obstruct Pulmon Dis; 2013; 8():107-16. PubMed ID: 23525511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of endoscopic sinus surgery on nasal spray deposition using dye-based methods for humans and a human silicone sinonasal cavity model.
    Ikeda K; Harashima T; Koike T
    Am J Otolaryngol; 2021; 42(6):103058. PubMed ID: 33932624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of intranasal corticosteroid sprays during pregnancy: an updated review.
    Alhussien AH; Alhedaithy RA; Alsaleh SA
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):325-333. PubMed ID: 29164323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.